non small cell lung cancer
OncomiRs, A Promising Target To Treat Lung Cancer
Researchers have discovered a class of small RNA molecules, known as oncomiRs, which is responsible for fueling lung cancer.
Researchers Identify Early Lung Cancer Biomarker
HIP1 could serve as a biomarker of early lung cancer, helping patients get diagnosed and treated as soon as possible.
CBMG Acquires CD40LGVAX Technologies
Building on positive Phase I results, the CD40LGVAX vaccine will undergo further trials in the second half of 2015.
Capturing CTCs With A Nanotech “Espresso Machine”
By raising and lowering the temperature, researchers have made the isolation of circulating tumor cells more efficient.
HSA Approves Lung Cancer Drug Giotrif®
Singaporean non-small cell lung cancer patients with EGFR mutations can look forward to new treatment possibilities with Boehringer Ingelheim's Giotrif®.
Pfizer To Conduct NSCLC Drug Trial In Asia
Pfizer Inc. will conduct a clinical trial of its crizotinib drug, marketed under the trademark Xalkori®, in four Asian countries.
Takeda Initiates Phase 3 Trial For Lung Cancer Drug
Takeda Pharma announced yesterday the initiation of a Phase 3 clinical trial involving 400 patients across Japan, Hong Kong, South Korea, and Taiwan.
Kyowa Kirin Starts Phase III Trial Of ARQ197/Erlotinib In NSC Lung Cancer
Kyowa Hakko Kirin is starting a Phase III trial evaluating the combination of ARQ 197 (tivantinib) and erlotinib in Asia for patients with advanced or metastatic non-small cell lung cancer.
